Clinical Trials
6 trialsNCT02262325 2025-06-12
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT04003246 2025-03-21
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT00346320 2023-08-04
Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Canadian Cancer Trials Group
Phase NA Completed
NCT00520702 2018-10-05
3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00280150 2017-06-19
Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Completed
NCT01176487 2016-03-31
Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34
Cancer Trials Ireland
Phase NA Completed